Anika to Issue First Quarter 2021 Financial Results on Thursday, May 6, 2021
April 15 2021 - 5:15PM
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint
preservation company in early intervention orthopedics, today
announced that the Company plans to issue its first quarter 2021
financial results after the close of the market on Thursday, May 6,
2021 and hold its investor conference call on the same day, at 5:00
p.m. ET to discuss its financial results and business highlights.
The conference call can be accessed by dialing
1-800-437-2398 (toll-free domestic) or 1-856-344-9206
(international) and providing the conference ID number 6335822. A
live audio webcast will be available in the Investor Relations
section of Anika's website, www.anika.com. An accompanying slide
presentation also can be accessed via the Anika website. The call
will be archived and accessible on the same website shortly after
its conclusion.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint
preservation company that creates and delivers meaningful
advancements in early intervention orthopedic care. We partner with
physicians to understand what they need most to treat their
patients and we develop minimally invasive products that restore
active living for people around the world. We are committed to
leading in high opportunity spaces within orthopedics, including
osteoarthritis pain management, regenerative solutions, soft tissue
repair and bone preserving joint technologies. For more
information, please visit www.anika.com.
For Investor Inquiries:Anika Therapeutics, Inc.Mark Namaroff,
781-457-9287Executive Director, Investor Relations and Corporate
Communicationsinvestorrelations@anika.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024